Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-364.24%Cash Return on Invested Capital
VS
Market
Sector
Industry
History
$ 0.74Close
$ 0.58 - $ 3.8 52-Week Range
Ticker Information
Ticker
GTBPCompany Name
GT BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQGT BIOPHARMA INC - Cash Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
GTBP - CROIC Historical data
| Date | Cash Return on Invested Capital | Free Cash Flow | Invested Capital |
|---|---|---|---|
| 6/30/2025 | -364.24% | $ -10.42M | $ 2.86M |
| 3/31/2025 | 0% | $ -10.94M | $ -980K |
| 12/31/2024 | 0% | $ -12.9M | $ -1.67M |
| 9/30/2024 | -595.28% | $ -12.48M | $ 2.1M |
| 6/30/2024 | -212.6% | $ -11.71M | $ 5.51M |
| 3/31/2024 | -189.24% | $ -10.11M | $ 5.34M |
| 12/31/2023 | -117.49% | $ -8.85M | $ 7.53M |
| 9/30/2023 | -109.96% | $ -11.1M | $ 10.1M |
| 6/30/2023 | -101.46% | $ -12.06M | $ 11.88M |
| 3/31/2023 | -97.79% | $ -12.91M | $ 13.2M |
Key Performance Insights, Last 5 Years
- GT BIOPHARMA INC's latest trailing twelve months (TTM) CROIC stands at 0%.
- Over the past 5 years, GT BIOPHARMA INC's average CROIC has been -149.47%.
- The median CROIC for GT BIOPHARMA INC during this period was -100.64%
- GT BIOPHARMA INC reached its highest CROIC over the past 5 years at -31.79%.
- The lowest CROIC recorded by GT BIOPHARMA INC in the same timeframe -595.28%
Similar metrics to Inv. Capital:
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditures Margin - [Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Cash Return on Invested Capital
[Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].FCF / Inv. Capital
(=) CROIC CROIC for GT BIOPHARMA INC is calculated as follows: FCF [ $ -5.82M ] / Inv. Capital [ $ -6.5M ]
(=) CROIC [ 0% ] GTBP - Cash Return on Invested Capital, Last 5 years
-595.28%
Minimum
Sep 30, 2024
-31.79%
Maximum
Jun 30, 2021
-149.47%
Average
-100.64%
Median
CROIC Benchmark AnalysisMarket
The chart above depicts the distribution of CROIC for companies in the Total Stock Market. The average CROIC of the companies is 2.84% with a standard deviation of 15.02%.
The following table provides additional summary stats:
CROIC in the Market:
| filtered constituents | 3.46K |
|---|---|
| min | -43.78% |
| max | 49.57% |
| average | 2.84% |
| median | 5.02% |
| std | 15.02% |